Nevada 2025 Regular Session

Nevada Assembly Bill AB19

Refer
11/6/24  
Introduced
2/4/25  
Report Pass
4/10/25  
Engrossed
4/15/25  
Refer
4/16/25  
Report Pass
5/19/25  
Enrolled
5/29/25  
Chaptered
6/3/25  

Caption

Revises provisions relating to the Statewide Substance Use Response Working Group. (BDR 40-442)

Companion Bills

No companion bills found.

Previously Filed As

NV AB156

Revises provisions relating to substance use disorders. (BDR 40-331)

NV SB35

Revises provisions relating to controlled substances. (BDR 40-423)

NV AB115

Revises provisions relating to substance use disorders. (BDR 40-726)

NV SB242

Requires the Department of Health and Human Services to establish the Psychedelic Medicines Working Group. (BDR S-39)

NV AB412

Revises provisions relating to juvenile justice. (BDR 5-492)

NV SB391A

Revises provisions relating to dentistry. (BDR 40-455)

NV SB385

Revises provisions relating to health care. (BDR 40-375)

NV AB516

Revises provisions relating to the Nevada Indian Commission. (BDR 18-1215)

NV AB7

Revises provisions relating to electronic health records. (BDR 40-381)

NV AB164

Revises provisions related to outdoor recreation. (BDR 35-487)

Similar Bills

US SB331

HALT Fentanyl Act Halt All Lethal Trafficking of Fentanyl Act

CA SB1448

Healing arts licensees: probation status: disclosure.

US HB467

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

US HB568

SAFE Act Save Americans from the Fentanyl Emergency Act

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

US HB27

HALT Fentanyl Act Halt All Lethal Trafficking of Fentanyl Act

CA AB888

Opioid prescriptions: information: nonpharmacological treatments for pain.

CA AB1103

Controlled substances: research.